Actively Recruiting
Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency
Led by GCS Ramsay Santé pour l'Enseignement et la Recherche · Updated on 2026-04-01
200
Participants Needed
1
Research Sites
359 weeks
Total Duration
On this page
Sponsors
G
GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead Sponsor
E
Euraxi Pharma
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of the study is to evaluate the oncological efficacy of pancreatic radiofrequency by the objective response rate (complete and partial responses according to RECIST 1.1.), 5 years after the end of treatment.
CONDITIONS
Official Title
Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 63; 18 years old
- Patient to be treated for a pancreatic tumor by ultrasound-guided radiofrequency with a fine needle
- Indication of pancreatic radiofrequency validated in a Multidisciplinary Consultation Meeting
- Patient able to understand the information related to the study
- Patient accepting study follow-up visits
- Patient having been informed and agreeing to participate in the study
You will not qualify if you...
- Patient with a contraindication to radiofrequency treatment
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHI Toulon La Seyne
Toulon, France, 83056
Actively Recruiting
Research Team
B
Bertrand NAPOLEON, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here